Navigation Links
QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
Date:8/22/2007

Multicenter Study Enrolls More Than 800 Women to Evaluate QuatRx's

New-Generation Selective Estrogen Receptor Modulator (SERM)

ANN ARBOR, Mich., Aug. 22 /PRNewswire/ -- QuatRx Pharmaceuticals, a privately-held biopharmaceutical company focused on development and commercialization of compounds to treat endocrine, metabolic and cardiovascular disorders, today announced that it has completed enrollment of a pivotal Phase 3 clinical trial of Ophena(TM) (ospemifene), the company's estrogen-free oral therapy in development for the treatment of vaginal symptoms associated with menopause.

Ophena(TM) is a new-generation selective estrogen receptor modulator (SERM) for postmenopausal vaginal syndrome (PVS), a common condition in postmenopausal women sometimes referred to as vaginal atrophy and characterized by vaginal symptoms such as dryness, irritation and sexual pain. Phase 2 clinical trials with Ophena(TM) demonstrated beneficial effects on vaginal epithelium and bone markers. In addition, in a Phase 2 trial, Ophena(TM) did not induce hot flashes in postmenopausal women when compared to placebo.

Patient enrollment for the randomized, double-blind study has reached 827 post-menopausal women at 80 trial centers throughout the United States. Women participating in the study are treated with either a 30- or 60-mg once daily oral dose of Ophena(TM) or placebo for 12 weeks. The study is the first of two pivotal Phase 3 efficacy trials planned for the compound.

"Completion of enrollment for this first Ophena(TM) Phase 3 trial is a significant development milestone," said Robert L. Zerbe, M.D., chief executive officer and president of QuatRx. "In this pivotal study we are seeking to confirm the beneficial vaginal effects already seen in our Phase 2 program. Millions of women suffer from such post-menopausal symptoms for which there are no oral non-estrogen treatments available. Ophena(TM) is specifically designed to address a major unmet
'/>"/>

SOURCE QuatRx Pharmaceuticals Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
2. Celsion Completes Enrollment in Phase I Liver Cancer Study
3. LANI completes Phase I in Japan and to commence Phase I in UK
4. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
5. Monitoring Patient Glucose Levels: New Advances in software make it easier
6. Managing Preanalytical Processes for Patient Safety
7. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
8. Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... This Defibrillators are critical life saving devices ... across globe. This report provides in-depth analysis of defibrillators ... . Stakeholders for this report include manufacturers of ... bodies. The Saudi Arabia defibrillators ... and by end users. In terms of products the ...
(Date:9/3/2015)... 2015 Nevro Corp. (NYSE: NVRO ), ... evidence-based solutions for the treatment of chronic pain, today ... Morgan Stanley Global Healthcare Conference on Thursday, September 17, ... management is scheduled to present at 11:45 a.m. ET. ... webcast, accessible in the "Investors" section of the company,s ...
(Date:9/3/2015)... , Sept. 3, 2015  Ascendis ... clinical stage biotechnology company that applies its ... medical needs, today announced plans to present ... Wells Fargo Healthcare Conference in BostonDate: , ... , Bank of America Merrill Lynch Global ...
Breaking Medicine Technology:Saudi Arabia Defibrillators Market: & Advanced Life Support Defibrillators; End Users; Industry Analysis, Size, Volume, Growth, Trends and Forecast 2014 - 2020 2Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences 2
... publishing group,s leading brands European Medical Device Technology ... Industry ( MD+DI ) and Qmed® ... on May 24, 2011.  Devoted to developments in materials for ... opportunity to learn from and interact directly with industry experts, ...
... Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic implants, ... Geelong, Australia by Richard S. Page, MB.BS.FRACS(ORTH) at St. John ... 57-year-old, active male with increasing shoulder pain for over a ... bike and not improved by a full range of non-surgical ...
Cached Medicine Technology:UBM Canon's Virtual Event Dedicated to Developments in Materials for Medical Applications 2UBM Canon's Virtual Event Dedicated to Developments in Materials for Medical Applications 3Ascension Orthopedics Implants PyroTITAN™ in Geelong, Australia 2
(Date:9/4/2015)... ... September 04, 2015 , ... The conference program ... Hollywood, Florida October 9-10, 2015 at the Diplomat Resort & Spa has been ... doctors and researchers at the top of their field and will be presenting ...
(Date:9/4/2015)... ... September 04, 2015 , ... Steven Winter Associates, Inc., ... has been selected for the Residential Award of Merit by the Connecticut Green ... Chosen from a highly competitive field of submissions, the net-zero energy residence will ...
(Date:9/4/2015)... ... 2015 , ... EMED Jamaica Global Ltd. (EMED), Jamaica’s premier ... into a multi-year agreement with Health City Cayman Islands. , ( http://www.healthcitycaymanislands.com ) ... healthcare, Jamaican healthcare and Health City Cayman Islands to deliver high-quality, affordable healthcare ...
(Date:9/3/2015)... Calif. (PRWEB) , ... September 03, 2015 , ... Allied ... Fullerton, where innovative medicine is the norm not the exception. , St. Jude was ... the American Heart Association/American Stroke Association, making it one of only 10 hospitals in ...
(Date:9/3/2015)... ... September 03, 2015 , ... The Oregon Collaborative ... of Integrative Health & Medicine (AIHM) Interprofessional Fellowship in Integrative Health & Medicine. ... MD, an internationally renowned educator, physician and thought leader in integrative medicine. This ...
Breaking Medicine News(10 mins):Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 2Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 3
... larger tumors , , THURSDAY, March 19 (HealthDay News) -- ... tumor improves tumor-free survival, a U.S. study has confirmed. ... cancer of the intestinal tract, typically occur in the ... are diagnosed in the United States each year. According ...
... Pharmaceuticals (NYSE: VRX ) today announced that ... of President, Valeant Pharmaceuticals International, effective March 10, 2009. ... for overseeing the Dow Services business, corporate business development ... and will be a member of Valeant,s Executive Management ...
... Abaxis, Inc. (Nasdaq: ABAX ), a ... today that Don Wood, vice president of operations, will ... on Thursday, March 26, 2009. The conference is a ... be held at the Cliff Lodge Snowbird Ski Resort ...
... Based on its recent analysis of the medical ... with the 2009 North American Frost & Sullivan ... The honor serves as recognition of the growth ... upon since the firm,s acquisition of Dynamic Imaging ...
... Anesthesiologists, Action vs. RhetoricCORONA DEL MAR, Calif., March 19 ... fair odds. Yet, that,s exactly what the foremost international ... the stage for last week when he responded to ... release in which they claimed to be in the ...
... ... OH (PRWEB) March 19, 2009 -- Female patients who require the removal ... extracted completely through the vagina, thanks to a new surgical procedure developed ... , , ,Dr. Jihad Kaouk, Director of the Center for Laparoscopic and ...
Cached Medicine News:Health News:Gleevec Prevents Return of Intestinal Cancer, Study Confirms 2Health News:Valeant Pharmaceuticals Appoints President of Valeant Pharmaceuticals International 2Health News:Valeant Pharmaceuticals Appoints President of Valeant Pharmaceuticals International 3Health News:Frost & Sullivan Recognizes GE Healthcare for Strategic Leadership in Acquiring Dynamic Imaging to Grow Its Imaging Informatics Business 2Health News:Frost & Sullivan Recognizes GE Healthcare for Strategic Leadership in Acquiring Dynamic Imaging to Grow Its Imaging Informatics Business 3Health News:Frost & Sullivan Recognizes GE Healthcare for Strategic Leadership in Acquiring Dynamic Imaging to Grow Its Imaging Informatics Business 4Health News:Frost & Sullivan Recognizes GE Healthcare for Strategic Leadership in Acquiring Dynamic Imaging to Grow Its Imaging Informatics Business 5Health News:Dr. Barry Friedberg comments on David vs. Goliath: Who's Really in the Pursuit of Patient Safety & Satisfaction? 2Health News:Cleveland Clinic First To Perform Nephrectomy Completely Transvaginally 2Health News:Cleveland Clinic First To Perform Nephrectomy Completely Transvaginally 3
Complete Blink-N-Clean lens drops cleans and clears lenses in a blink. It is a unique blend of gentle to the eye ingredients that conveniently cleans, clears and keeps lenses feeling comfortable thro...
Renu rewetting drops soothe your eyes and moisturize soft contact lenses to minimize dryness....
Softwear Saline with unique comfort rinsing formula....
Sensitive Eyes sterile saline spray is the preservative-free aerosol saline solution for people with eyes sensitive to preservatives. Used for rinsing soft contact lenses after cleaning or thermal or...
Medicine Products: